Sterling Capital Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.15M	Sell	16,564 -1,984	-11%	-$494K	0.08%	205
2025 Q4	$5.1M	Sell	18,548 -1,714	-8%	-$469K	0.08%	193
2025 Q3	$5.32M	Buy	20,262 +67	+0.3%	+$16.3K	0.08%	172
2025 Q2	$4.42M	Buy	20,195 +3,017	+18%	+$645K	0.06%	215
2025 Q1	$3.85M	Sell	17,178 -690	-4%	-$190K	0.06%	217
2024 Q4	$5.85M	Buy	17,868 +473	+3%	+$149K	0.08%	178
2024 Q3	$5.22M	Buy	+17,395	New	+$5.33M	0.07%	209
2019 Q3	$27.8M	Sell	196,173 -25,500	-12%	-$3.51M	0.26%	111
2019 Q2	$27.7M	Hold	221,673	–	–	0.27%	109
2019 Q1	$24.4M	Sell	221,673 -50,000	-18%	-$5.2M	0.24%	121
2018 Q4	$26.6M	Sell	271,673 -65,232	-19%	-$7.08M	0.29%	108
2018 Q3	$41.6M	Hold	336,905	–	–	0.38%	94
2018 Q2	$33.5M	Hold	336,905	–	–	0.31%	96
2018 Q1	$29.7M	Buy	336,905 +39,424	+13%	+$3.69M	0.28%	108
2017 Q4	$29.4M	Sell	297,481 -44,979	-13%	-$4.41M	0.27%	102
2017 Q3	$33M	Buy	342,460 +15,160	+5%	+$1.37M	0.31%	98
2017 Q2	$30.9M	Sell	327,300 -70,000	-18%	-$6.44M	0.3%	98
2017 Q1	$32.4M	Sell	397,300 -654	-0.2%	-$54.7K	0.31%	98
2016 Q4	$33.8M	Sell	397,954 -37,346	-9%	-$2.94M	0.3%	96
2016 Q3	$32.4M	Hold	435,300	–	–	0.3%	95
2016 Q2	$33M	Sell	435,300 -117,000	-21%	-$8.51M	0.3%	98
2016 Q1	$38.3M	Sell	552,300 -96,000	-15%	-$5.78M	0.35%	95
2015 Q4	$39M	Hold	648,300	–	–	0.35%	97
2015 Q3	$35.1M	Buy	+648,300	New	+$37.8M	0.31%	104